Skip to content

ELAVL3 Exacerbates Brain Injury and Cognitive Dysfunction in Mice After Cardiac Arrest by Increasing S100B mRNA Stability to Promote Microglia Activation

Sep 2026 · Journal of Neuroimmune Pharmacology · Vol 21 · 0 citations · 18 references
Medicine

TL;DR

This study identifies the ELAVL3/S100B axis as a key driver of post-ischemic neuroinflammation and Targeting this pathway may offer a potential therapeutic strategy for cerebral ischemic injuries.

View source

Similar papers

Open access Sep 2026

CD147 exacerbates ischemic brain injury and disrupts Wnt/β-catenin signaling and blood-brain barrier integrity

CD147 exacerbates ischemic brain injury and BBB disruption by suppressing neuronal Wnt/β-catenin signaling through a mechanism involving the AKT/GSK3β node, supporting further evaluation of CD147-directed interventions after stroke.

Yue-Qing Wang, F. Ogunleye, Chong-Lin Xu et al. · 0 citations
Aug 2026

Microglial RIOK3 promotes post-ischemic neuroinflammation by facilitating YBX1 phosphorylation and nuclear accumulation.

Microglia-targeted RIOK3 knockdown reduced infarct volume, improved early neurological and sensorimotor outcomes, preserved microglial process complexity, and reduced post-ischemic inflammation, and highlight the RIOK-YBX1 axis as a potential therapeutic target for ischemic stroke.

Yang Geng, Ningning Zong, Chao Zhou et al. · 0 citations
Sep 2026

C21 ameliorates microglial ferroptosis and neuronal apoptosis after ischemic brain injury by activating the METTL3/USP18/FASN axis.

BACKGROUND Microglial ferroptosis is a key risk factor promoting neuroinflammation after ischemic brain injury (IBI). Although Compound 21 (C21) has neuroprotective and anti-inflammatory properties, its role in modulating microglial ferroptosis in IBI remains unexplored. METHODS IBI was induced in C57BL/6 mice via tr...

Yi-Jiu Wu, Xin-Qiang Zhou, Xu-Fang Huo et al. · 0 citations
Sep 2026

TREM1/DAP12-mediated neuron-microglia crosstalk in ischemic stroke: Huangxiong formula reduces Neuroinflammation and neuronal Pyroptosis.

Microglial TREM1 represents a key therapeutic target, supporting the clinical application of HXF for ischemic stroke, and HXF alleviates neuroinflammation and neuronal pyroptosis by inhibiting microglial M1 polarization through the TREM1/DAP12 pathway.

Ping-Ping Zhang, Wen-Hui Xia, Yue-Ting Huang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.